Science Current Events | Science News | Brightsurf.com
 

Immune Response Current Events | Immune Response News | 8

Sort By: Page Views | Date

Scientists Develop Method to Track Immune System Enzyme in Live Animals
Scientists supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health have created two mouse strains that will permit researchers to trace, in a live animal, the activity of an enzyme believed to play a crucial role both in the normal immune response as well as autoimmunity... view more... (2007-05-18)

Scientists learn why the flu may turn deadly
As the swine flu continues its global spread, researchers from the Children's Hospital of Philadelphia, Pennsylvania, have discovered important clues about why influenza is more severe in some people than it is in others.   view more (2009-05-05)

Cellular antacids give vaccines a boost
Scientists in Italy have found that a drug that blocks acid buildup inside cells revs up the immune response to vaccines.   view more (2005-09-12)

A Jekyll and Hyde of cytokines: IL-25 both promotes and limits inflammatory diseases
The same signal responsible for promoting the type of immune responses that cause asthma and allergy can also limit the type of inflammation associated with debilitating diseases like inflammatory bowel disease, arthritis and multiple sclerosis.   view more (2006-04-10)

Ben-Gurion University Alzheimer's researcher demonstrates specific immune response to vaccine
A researcher who is working on a vaccine for Alzheimer's disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer's patients.   view more (2009-09-21)

Anthrax attack posed greater potential threat than thought
A new study shows that more people were at risk of anthrax infection in the Oct. 2001 attack on U.S. Sen. Tom Daschle's office than previously known.   view more (2007-01-05)

How HIV vaccine might have increased odds of infection
In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection.   view more (2008-11-03)

New 'adjuvant' could hold future of vaccine development
Scientists at Oregon State University have developed a new "adjuvant" that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical experts tackle many diseases more effectively.   view more (2009-09-15)

Bird flu vaccine additive may stretch supply
Researchers have achieved an effective immune response to an avian influenza vaccine with doses as low as one-quarter of the norm when they added a chemical mixture known as MF59.   view more (2006-09-26)

Early-stage immune system control of HIV may depend on inherited factors
How well an individual's immune system controls HIV during the earliest phases of infection appears to depend on both the specific versions of key immune-system molecules called HLA Class I that have been inherited, as well as on the fragments of viral protein those molecules display to the T lymphocytes that usually destroy infected cells.   view more (2006-11-06)

Scientists find a key to immune system's ability to remember
Its ability to accurately catalog and recall long past encounters with viruses, bacteria and other pathogens is why we only get the measles or chicken pox once, and is why exposure to deactivated virus particles in vaccines confers protection from disease.   view more (2006-10-24)

Malaria treatment efficacy compromised in certain HIV-positive patients
A weakened immune response resulting from HIV infection can lead to trouble when it comes to treating malaria.   view more (2006-09-08)

Study gives clues about how deadly bacterium gains foothold
How a potentially deadly bacterium that could be used as a bioterrorist tool eludes being killed by the human immune system is now better understood.   view more (2006-12-20)

University of Pennsylvania Researchers Discover "Killer" B Cells; New Link in the Evolution of Immunity
Researchers from the University of Pennsylvania School of Veterinary Medicine have discovered a unique evolutionary link between the immune systems of fish and mammals in the form of a primitive version of B cells, white blood cells of the immune system.   view more (2006-09-21)

Second pathway behind HIV-associated immune system dysfunction identified
Researchers at the Partners AIDS Research Center at Massachusetts General Hospital (PARC-MGH) may have discovered a second molecular "switch" responsible for turning off the immune system's response against HIV.   view more (2007-10-01)

LIAI finding gives boost to bioinformatics use in fighting disease
The use of computers to advance human disease research — known as bioinformatics — has received a major boost from researchers at the La Jolla Institute for Allergy & Immunology (LIAI), who have used it to successfully predict immune response to one of the most complex viruses known to man — the vaccinia virus, which is used... view more... (2006-06-16)

Scientists develop fungus-fighting vaccine
group of scientists in Italy have developed a vaccine with the potential to protect against fungal pathogens that commonly infect humans, according to a study by Torosantucci and colleagues in the September 5 issue of The Journal of Experimental Medicine.   view more (2005-09-06)

Study gives clues about how deadly bacterium gains foothold
How a potentially deadly bacterium that could be used as a bioterrorist tool eludes being killed by the human immune system is now better understood, University of Iowa researchers report in the December issue of the Journal of Leukocyte Biology.   view more (2006-12-19)

Second TroVax Phase I/II trial results presented at the 94th annual meeting of the American Association for Cancer Research
Oxford, UK: 14 July 2003 - Oxford BioMedica announced today that it is presenting new clinical data on the Company's lead cancer product, TroVax®, at the American Association for Cancer Research (AACR) Annual Meeting in Washington, DC. The results are being presented by Dr. Richard Harrop, Principal Scientist at Oxford BioMedica. Following on... view more... (2003-07-14)

Combining math and medicine to treat leukemia
Researchers have produced a mathematical model that may lead to the development of an optimally-timed vaccine for chronic myelogenous leukemia (CML).   view more (2008-06-20)
Sort By: Page Views | Date
© 2009 BrightSurf.com